Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Cash from Financing Activities: 2011-2024

Historic Cash from Financing Activities for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $4.9 million.

  • Veracyte's Cash from Financing Activities fell 71.07% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year decrease of 185.33%. This contributed to the annual value of $4.9 million for FY2024, which is 72.86% up from last year.
  • According to the latest figures from FY2024, Veracyte's Cash from Financing Activities is $4.9 million, which was up 72.86% from $2.8 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Cash from Financing Activities peaked at $596.3 million during FY2021, and registered a low of $2.8 million during FY2023.
  • In the last 3 years, Veracyte's Cash from Financing Activities had a median value of $3.5 million in 2022 and averaged $3.7 million.
  • In the last 5 years, Veracyte's Cash from Financing Activities skyrocketed by 192.90% in 2021 and then slumped by 99.41% in 2022.
  • Veracyte's Cash from Financing Activities (Yearly) stood at $203.6 million in 2020, then surged by 192.90% to $596.3 million in 2021, then plummeted by 99.41% to $3.5 million in 2022, then decreased by 18.80% to $2.8 million in 2023, then skyrocketed by 72.86% to $4.9 million in 2024.